Gary Loeb Sells 300 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now owns 1,595 shares of the company’s stock, valued at $757,625. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Intuitive Surgical Stock Up 1.6 %

Intuitive Surgical stock traded up $7.57 during midday trading on Monday, hitting $479.39. The company’s stock had a trading volume of 1,120,515 shares, compared to its average volume of 1,516,293. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $493.97. The stock’s 50-day moving average price is $458.74 and its 200-day moving average price is $418.53. The company has a market capitalization of $170.04 billion, a PE ratio of 86.53, a price-to-earnings-growth ratio of 5.20 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the previous year, the firm earned $1.18 EPS. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Sanctuary Advisors LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth $22,957,000. Clear Rock Advisors LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at $216,000. Sycomore Asset Management increased its stake in Intuitive Surgical by 28.6% in the 2nd quarter. Sycomore Asset Management now owns 9,120 shares of the medical equipment provider’s stock worth $4,036,000 after purchasing an additional 2,027 shares in the last quarter. Clearbridge Investments LLC raised its holdings in Intuitive Surgical by 1.6% during the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock worth $881,380,000 after buying an additional 30,449 shares during the period. Finally, Dana Investment Advisors Inc. lifted its stake in Intuitive Surgical by 5.0% during the second quarter. Dana Investment Advisors Inc. now owns 1,904 shares of the medical equipment provider’s stock valued at $847,000 after buying an additional 90 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. Stifel Nicolaus lifted their target price on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Truist Financial raised their price target on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, BTIG Research increased their price target on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.